Unitil Schedules Fourth Quarter 2022 Earnings Release and
HAMPTON, N.H., Jan. 27, 2023 (GLOBE NEWSWIRE) -- Unitil Corporation (NYSE: UTL) (unitil.com) has scheduled the release
Globe Newswire27-01-2023, 18:48
Positive Phase 1b/2 Results from Ongoing REC-4881 TUPELO Trial Demonstrate Rapid and Durable Reductions in Polyp Burden in Familial Adenomatous Polyposis (FAP) at 25 Weeks 8-12-2025, 19:30